
RSV / SARS-CoV-2 / Influenza A/B Combo Rapid Antigen Test Kit (RAT-19)
The HA TECH Respiratory Combo Panel RSV/SARS-CoV-2/Influenza A/B Combo Rapid Antigen Test Kit(RAT-19) is intended to aid in the differential diagnosis of RSV, COVID-19, Influenza A, and Influenza B in symptomatic patients via the qualitative detection of RSV, SARS-CoV-2, Influenza A, and Influenza B nucleocapsid protein antigens.
This test is intended for home use with nasal swab specimen from individuals who have experienced COVID-19 like symptoms within the last 7 days, or RSV/Influenza-like symptoms within the last 4 days.
Qualitative detection of Respiratory Syncytial Virus (RSV), SARS-CoV-2, and Influenza A/B antigens in a single test
High specificity and sensitivity, ensuring accurate and reliable results
Self-testing convenience, suitable for home use
The HA TECH Respiratory Combo Panel RSV/SARS-CoV-2/Influenza A/B Combo Rapid Antigen Test Kit(RAT-19) is intended to aid in the differential diagnosis of RSV, COVID-19, Influenza A, and Influenza B in symptomatic patients via the qualitative detection of RSV, SARS-CoV-2, Influenza A, and Influenza B nucleocapsid protein antigens.
This test is intended for home use with nasal swab specimen from individuals who have experienced COVID-19 like symptoms within the last 7 days, or RSV/Influenza-like symptoms within the last 4 days.
Qualitative detection of Respiratory Syncytial Virus (RSV), SARS-CoV-2, and Influenza A/B antigens in a single test
High specificity and sensitivity, ensuring accurate and reliable results
Self-testing convenience, suitable for home use
Original: $48.31
-65%$48.31
$16.91Description
The HA TECH Respiratory Combo Panel RSV/SARS-CoV-2/Influenza A/B Combo Rapid Antigen Test Kit(RAT-19) is intended to aid in the differential diagnosis of RSV, COVID-19, Influenza A, and Influenza B in symptomatic patients via the qualitative detection of RSV, SARS-CoV-2, Influenza A, and Influenza B nucleocapsid protein antigens.
This test is intended for home use with nasal swab specimen from individuals who have experienced COVID-19 like symptoms within the last 7 days, or RSV/Influenza-like symptoms within the last 4 days.
Qualitative detection of Respiratory Syncytial Virus (RSV), SARS-CoV-2, and Influenza A/B antigens in a single test
High specificity and sensitivity, ensuring accurate and reliable results
Self-testing convenience, suitable for home use







